Parexel International Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Parexel International Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11520
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among several others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Waltham, Massachusetts, the US.

Parexel International Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10
Parexel International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Parexel International Corp, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Pamplona Capital Management Acquires Parexel International for USD5 Billion 12
Partnerships 14
Parexel Enters into Agreement with Microsoft 14
Parexel Enters into Agreement with Osaka International Cancer 15
InDex Pharma Enters into Agreement with Parexel 16
Polus Enters into Agreement with Parexel 17
Parexel International Enters Into Agreement With National Taiwan University Hospital 18
Debt Offering 19
Parexel International Completes Private Placement Of Notes Due 2020 For US$100 Million 19
Acquisition 20
Parexel International Acquires Medical Affairs Company 20
Parexel International Acquires Quantum Solutions, Contract Research Organization 21
Parexel Acquires ClinIntel 22
Parexel International Acquires Atlas Medical 23
Parexel Acquires Heron Group For USD37 Million 24
Parexel International Acquires Liquent For USD74.3 Million 25
Parexel International Corp – Key Competitors 26
Parexel International Corp – Key Employees 27
Parexel International Corp – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 33
Financial Announcements 33
Aug 28, 2017: PAREXEL International Reports Fourth Quarter and Fiscal Year 2017 Results 33
May 03, 2017: PAREXEL International Reports Third Quarter Fiscal Year 2017 Results 34
Feb 01, 2017: PAREXEL International Reports Second Quarter Fiscal Year 2017 Results 36
Corporate Communications 38
Nov 12, 2018: Parexel announces appointment of new members to its Board of Directors 38
Aug 16, 2018: PAREXEL announces appointment of two key executives 40
Apr 25, 2018: PAREXEL Names Peyton Howell as Chief Commercial and Strategy Officer 41
Mar 05, 2018: PAREXEL Names Jamie Macdonald As Chief Executive Officer 42
Feb 28, 2017: PAREXEL International Appoints Simon Harford as Senior Vice President and Chief Financial Officer 43
Government and Public Interest 44
May 15, 2018: CRO Industry Update: Big Data Drives Drug Development Efforts 44
Other Significant Developments 47
Oct 31, 2018: PAREXEL navigates China’s complex drug development and market landscape for global biopharmaceutical companies with new China Advisory Service 47
Sep 11, 2018: PAREXEL advances patient-centric drug development with introduction of its patient innovation center 48
Mar 21, 2018: PAREXEL Introduces Integrated Medical Writing Solutions Service Offering 49
Feb 12, 2018: PAREXEL Introduces Biological Sample Lifecycle Management Service to Address Growing Demand Across Drug Development 50
Sep 06, 2017: PAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments 51
Jun 19, 2017: PAREXEL Introduces Its Connected Journey of Newly Integrated Data-Driven Services to Simplify Drug Development and Commercialization 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Parexel International Corp, Pharmaceuticals & Healthcare, Key Facts 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10
Parexel International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Pamplona Capital Management Acquires Parexel International for USD5 Billion 12
Parexel Enters into Agreement with Microsoft 14
Parexel Enters into Agreement with Osaka International Cancer 15
InDex Pharma Enters into Agreement with Parexel 16
Polus Enters into Agreement with Parexel 17
Parexel International Enters Into Agreement With National Taiwan University Hospital 18
Parexel International Completes Private Placement Of Notes Due 2020 For US$100 Million 19
Parexel International Acquires Medical Affairs Company 20
Parexel International Acquires Quantum Solutions, Contract Research Organization 21
Parexel Acquires ClinIntel 22
Parexel International Acquires Atlas Medical 23
Parexel Acquires Heron Group For USD37 Million 24
Parexel International Acquires Liquent For USD74.3 Million 25
Parexel International Corp, Key Competitors 26
Parexel International Corp, Key Employees 27
Parexel International Corp, Other Locations 28
Parexel International Corp, Subsidiaries 29

List of Figures
Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Parexel International Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AGF Management Ltd:企業の戦略・SWOT・財務分析
    AGF Management Ltd - Strategy, SWOT and Corporate Finance Report Summary AGF Management Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Concord Medical Services Holdings Ltd (CCM):製薬・医療:M&Aディール及び事業提携情報
    Summary Concord Medical Services Holdings Ltd (CMS) is a diagnostic imaging center that offers clinical support services and laboratory services. The center offers radiotherapy and diagnostic imaging equipment services such as head gamma knife systems, body gamma knife systems and linear accelerator …
  • Dominion Energy South Carolina Inc:企業の戦略的SWOT分析
    Dominion Energy South Carolina Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Storz Medical AG:企業の戦略的SWOT分析
    Storz Medical AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Fresenius SE & Co KGaA (FRE)-医療機器分野:企業M&A・提携分析
    Summary Fresenius SE & Co KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes mach …
  • National Industrialization Co (2060):企業の財務・戦略的SWOT分析
    National Industrialization Co (2060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Orange SA:企業の戦略・SWOT・財務情報
    Orange SA - Strategy, SWOT and Corporate Finance Report Summary Orange SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Reliance Infrastructure Ltd (RELINFRA):企業の財務・戦略的SWOT分析
    Reliance Infrastructure Ltd (RELINFRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Bioverativ Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant antihemophilic factor engineered using Fc fusion technolog …
  • ALung Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary ALung Technologies Inc (ALung Technologies) is a medical device company that develops devices for treating patients with acute respiratory failure. The company's Hemolung Respiratory Assist System(RAS) provides respiratory dialysis that removes carbon dioxide and delivers oxygen directly to …
  • Origin Energy Ltd (ORG):電力:M&Aディール及び事業提携情報
    Summary Origin Energy Ltd (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water stora …
  • BYD Co Ltd (1211):電力:M&Aディール及び事業提携情報
    Summary BYD Co Ltd (BYD) designs, manufactures and sells rechargeable batteries, photovoltaic products, handset components, and other electronic products. It also offers whole product assembly services. The company manufactures and offers traditional fuel-engine vehicles and new energy vehicles. The …
  • The Kyoto Hotel, Ltd.
    The Kyoto Hotel, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Kyoto Hotel, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Vivergo Fuels Ltd:企業の戦略的SWOT分析
    Vivergo Fuels Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Viridian Group Investments Ltd:企業の戦略的SWOT分析
    Viridian Group Investments Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Catalina Holdings (Bermuda) Ltd:企業のM&A・事業提携・投資動向
    Catalina Holdings (Bermuda) Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Catalina Holdings (Bermuda) Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Agilent Technologies Inc (A):企業の財務・戦略的SWOT分析
    Agilent Technologies Inc (A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sonatrach SPA-石油・ガス分野:企業M&A・提携分析
    Summary Sonatrach SPA (Sonatrach) is a state-owned integrated oil and gas company. Its businesses include exploration and production; pipeline transportation; liquefaction, refining and petrochemicals; marketing of petroleum products; maritime transportation; and other services. The company explores …
  • J D Wetherspoon plc (JDW):企業の財務・戦略的SWOT分析
    J D Wetherspoon plc (JDW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • TG Therapeutics Inc (TGTX):製薬・医療:M&Aディール及び事業提携情報
    Summary TG Therapeutics Inc (TG Therapeutics) is a biopharmaceutical company which acquires, develops and commercializes pharmaceutical products for the treatment of B-cell malignancies and autoimmune diseases. The company develops two therapies, namely, TG-1101 (ublituximab) and TGR-1202 for the tr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆